ANXA2 and hepatocellular carcinoma: We found that LINC01133 increased the total protein level of ANXA2 and the phosphorylation levels of ANXA2 and STAT3 and also upregulated the downstream target gene cyclin D1 in HCC, which might account for its effects on HCC progression.